Position in MRNA
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$267,794
+$30,294 QoQ
Shares Held
3,824
+91.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#459
of 772 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Murphy Pohlad Asset Management LLC holds $2,455,172 across 2 Biotechnology names. MRNA ranks #2 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,508 | $2,187,378 | |
| 2 | MRNA |
Moderna, Inc.
This page
|
3,824 | $267,794 |
All Filings in MRNA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $267,794 | 3,824 | Shares | Sole | 2026-07-21 | |
| 2024-06-30 | $237,500 | 2,000 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $213,120 | 2,000 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $203,872 | 2,050 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $206,580 | 2,000 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $269,122 | 2,215 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $340,179 | 2,215 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $397,858 | 2,215 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $261,923 | 2,215 | Shares | Sole | 2022-10-24 | |
| No filing history on record for this holder in this stock. | ||||||